Veru VERU Stock
Veru Price Chart
Veru VERU Financial and Trading Overview
| Veru stock price | 3.04 USD |
| Previous Close | 2.95 USD |
| Open | 2.95 USD |
| Bid | 2.2 USD x 200 |
| Ask | 3.77 USD x 200 |
| Day's Range | 2.91 - 3.09 USD |
| 52 Week Range | 2.05 - 7.33 USD |
| Volume | 248.27K USD |
| Avg. Volume | 1.88M USD |
| Market Cap | 47.51M USD |
| Beta (5Y Monthly) | -1.128 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.82 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | April 28, 2014 |
| 1y Target Est | 24.5 USD |
VERU Valuation Measures
| Enterprise Value | 19.68M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.0050762 |
| PEG Ratio (5 yr expected) | 3.6 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.3659437 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.702 |
Trading Information
Veru Stock Price History
| Beta (5Y Monthly) | -1.128 |
| 52-Week Change | -55.82% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 7.33 USD |
| 52 Week Low | 2.05 USD |
| 50-Day Moving Average | 2.51 USD |
| 200-Day Moving Average | 2.73 USD |
VERU Share Statistics
| Avg. Volume (3 month) | 1.88M USD |
| Avg. Daily Volume (10-Days) | 983.24K USD |
| Shares Outstanding | 16.05M |
| Float | 13.48M |
| Short Ratio | 8.3 |
| % Held by Insiders | 9.78% |
| % Held by Institutions | 23.92% |
| Shares Short | 564.55K |
| Short % of Float | 3.89% |
| Short % of Shares Outstanding | 3.52% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 371.00% |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | September 30, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -46.42% |
| Return on Equity (ttm) | -51.73% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -28019146 USD |
| Net Income Avi to Common (ttm) | -14444090 USD |
| Diluted EPS (ttm) | -0.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 30.66M USD |
| Total Cash Per Share (mrq) | 1.91 USD |
| Total Debt (mrq) | 2.83M USD |
| Total Debt/Equity (mrq) | 8.15 USD |
| Current Ratio (mrq) | 6.19 |
| Book Value Per Share (mrq) | 2.167 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26058052 USD |
| Levered Free Cash Flow (ttm) | -14288895 USD |
Profile of Veru
| Country | United States |
| State | FL |
| City | Miami |
| Address | 2916 North Miami Avenue |
| ZIP | 33127 |
| Phone | 305 509 6897 |
| Website | https://verupharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 20 |
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Q&A For Veru Stock
What is a current VERU stock price?
Veru VERU stock price today per share is 3.04 USD.
How to purchase Veru stock?
You can buy VERU shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Veru?
The stock symbol or ticker of Veru is VERU.
Which industry does the Veru company belong to?
The Veru industry is Biotechnology.
How many shares does Veru have in circulation?
The max supply of Veru shares is 16.05M.
What is Veru Price to Earnings Ratio (PE Ratio)?
Veru PE Ratio is now.
What was Veru earnings per share over the trailing 12 months (TTM)?
Veru EPS is -0.82 USD over the trailing 12 months.
Which sector does the Veru company belong to?
The Veru sector is Healthcare.
Veru VERU included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech US Benchmark Personal Ca
NQUSB4520N
US
|
1433.32 USD — |
+2.1
|
— — | 1404.04 USD — | 1435.67 USD — | — - | — — |
|
US Tech Capital Market Composite
RCMP
US
|
146.53 USD — |
-0.75
|
— — | 144.14 USD — | 148.72 USD — | — - | — — |
|
US Tech US Benchmark Personal Ca
NQUSB4520CADN
US
|
1252.08 CAD 929.12 USD |
<0.01
|
— — | 1252.08 CAD 929.12 USD | 1252.08 CAD 929.12 USD | — - | — — |
|
US Tech Industrial
INDS
US
|
12594.75 USD — |
-0.7
|
— — | 12581.74 USD — | 12683 USD — | — - | — — |
- {{ link.label }} {{link}}